[{"AllocatedShareBasedCompensationExpense_2_Q3_USD":0.0,"NetIncomeLossAvailableToCommonStockholdersBasic_2_Q3_USD":2635844.0,"OperatingIncomeLoss_1_Q3_USD":2679618.0,"OperatingIncomeLoss_2_Q3_USD":2635844.0,"PaymentOfFinancingAndStockIssuanceCosts_2_Q3_USD":5000000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"PreferredStockSharesAuthorized_0_Q3_shares":5000000.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"PreferredStockValue_0_Q3_USD":null,"PrepaidExpenseCurrent_0_Q3_USD":840511.0,"ProceedsFromIssuanceInitialPublicOffering_2_Q3_USD":250000000.0,"ProceedsFromIssuanceOfCommonStock_2_Q3_USD":25000.0,"ProceedsFromIssuanceOfPrivatePlacement_2_Q3_USD":7000000.0,"ProceedsFromNotesPayable_2_Q3_USD":750000.0,"RedeemableNoncontrollingInterestEquityCommonCarryingAmount_0_Q3_USD":250000000.0,"RegistrationPaymentArrangementMaximumPotentialConsideration_0_Q3_USD":8750000.0,"RepaymentsOfNotesPayable_2_Q3_USD":750000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-24027933.0,"StockholdersEquity_0_Q3_USD":-24027308.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q3_USD":2679618.0,"NetCashProvidedByUsedInOperatingActivities_2_Q3_USD":350587.0,"NetCashProvidedByUsedInInvestingActivities_2_Q3_USD":-250000000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q3_USD":251600219.0,"Assets_0_Q3_USD":252791317.0,"AssetsCurrent_0_Q3_USD":2791317.0,"AssetsHeldInTrustNoncurrent_0_Q3_USD":250000000.0,"Cash_0_Q3_USD":1950806.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":1950806.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q3_USD":1950806.0,"CashFDICInsuredAmount_0_Q3_USD":250000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"DeferredCompensationLiabilityClassifiedNoncurrent_0_Q3_USD":8750000.0,"TemporaryEquityRedemptionPricePerShare_0_Q3_USD":10.0,"DerivativeGainLossOnDerivativeNet_1_Q3_USD":3653579.0,"DerivativeLiabilitiesCurrent_0_Q3_USD":15846421.0,"DividendsCommonStockCash_3_Q3_USD":0.0,"IncomeTaxExaminationPenaltiesAndInterestAccrued_0_Q3_USD":0.0,"IncreaseDecreaseInDerivativeLiabilities_2_Q3_USD":-3653579.0,"IncreaseDecreaseInPrepaidExpense_2_Q3_USD":840511.0,"Liabilities_0_Q3_USD":26818625.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":252791317.0,"LiabilitiesCurrent_0_Q3_USD":18068625.0,"LiabilitiesFairValueAdjustment_0_Q3_USD":-3653579.0,"DerivativeGainLossOnDerivativeNet_2_Q3_USD":3653579.0,"TemporaryEquitySharesOutstanding_0_Q3_shares":25000000.0,"Ticker":"AFTR","CIK":"1865975","name":"AFTERNEXT HEALTHTECH ACQUISITION CORP.","OfficialName":"AfterNext HealthTech Acquisition Corp. Class A Ordinary Shares","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"2","uom":"USD","footnote":"nan","Market Cap":"303437500.0","Country":"nan","Sector":"nan","Industry":"nan","Market":"NYSE","SP500":"nan","filed":"20211103"}]